Ferring Ventures Limited
1 clinical trials · Sponsor
◉ Watch Ferring Ventures Limited
| Record | Firm | Date |
|---|---|---|
| Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma (NCT03710876) | Ferring Ventures Limited | 2019-01-21 |
Track Ferring Ventures Limited automatically
Every clearance here is in the API, with alerts when new ones post.